glp 1 inhibitors for weight loss GLP-1 medications GLP-1 diabetes and weight-loss drug

Probiotic therapy of COVID-19 patients with a combination of nine different lactobacilli strains (as daily dose), showed significant alterations in gut microbiota, partial restoration of pulmonary dysfunction as well as intestinal dysbiosis

Research with senescent rhesus monkeys (aged 20-27 years) showed that Epithalon administration decreased basal plasma levels of glucose and insulin while increasing basal nighttime melatonin levelsreversing age-associated endocrine dysfunction patterns

What sets GLP-1 medications apart from previous generations of weight loss drugs is the breadth and depth of their mechanism

Identification of a putative Estrogen response element in the gene encoding brain-derived Neurotrophic factor